Design of cross-over trials for pharmacokinetic studies

Journal of Statistical Planning and Inference

Volumn 78, Issue 1-2, 1999, Pages 307-316

  Jones, B ^a   Wang, J ^a   Jarvis, P ^b   Byrom, W ^c  

^a DE MONTFORT UNIVERSITY   (United Kingdom)

^b ASTRAZENECA   (United Kingdom)

^c ABBOTT LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0033130224     PISSN: 03783758     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0378-3758(98)00221-3     Document Type: Article

References (20)

1. Al-Banna M.K., Kelman A.W., Whiting B. Experimental design and efficient parameter estimation in population pharmacokinetics. J. Pharmacokin. Biopharm. 18:1990;347-360.
2. Atkinson A.C. Recent developments in the methods of optimum and related experimental designs. Int. Statist. Rev. 56:1988;99-115.
3. Atkinson A.C. The usefulness of optimum experimental designs. J. Roy. Statist. Soc. B. 57:1995;59-76.
4. Atkinson A.C., Chaloner K., Herzberg A.M., Juritz J. Optimum experimental designs for properties of a compartmental model. Biometrics. 49:1993;325-337.
5. Bauer L. Primer on clinical pharmacokinetics. Am. J. Hosp. Pharm. 40:1983;1637-1641.
6. Chaloner K., Verdinelli I. Bayesian experimental design. a review Statistical Science. 10:1995;273-304.
7. Fedorov, V.V., 1972. Theory of Optimal Experiments. Academic Press, New York.
8. Ford I., Kitsos C.P., Titterington D.M. Recent advances in nonlinear experimental design. Technometrics. 21:1989;191-208.
9. Gabrielsson, J., Weiner, D., 1994. Pharmacokinetic and Pharmacodynamic Data Analysis. Swedish Pharmaceutical Press, Stockholm.
10. Hashimoto Y., Sheiner L.B. Designs for population pharmacodynamics. value of pharmacokinetic data and population analysis J. Pharmacokin. Biopharm. 19:1991;333-353.
11. Jones, B., Kenward, M.G., 1989. Design and Analysis of Cross-over Trials. Chapman & Hall, New York.
12. Jones B., Kunert J., Wynn H.P. Information matrices for mixed effects models with applications to the optimality of repeated measurements designs. J. Statist. Plann. Inference. 33:1992;261-274.
13. Kiefer J., Wolfowitz J. The equivalence of two extremum problems. Can. J. Math. 12:1960;363-366.
14. Merlé Y., Mentré F. Bayesian design criteria. computation, comparison and application to a pharmacokinetic and a pharmacodynamic model J. Pharmacokin. Biopharm. 23:1995;101-125.
15. Merlé Y., Mentré F., Mallet A., Aurengo A.H. Designing an optimal experiment for Bayesian estimation. application to the kinetics of iodine thyroid uptake Statist. Med. 13:1994;185-196.
16. Mentré F., Burtin P., Merlé Y., Bree J., Van Mallet A., Steimer J.L. Sparse-sampling optimal designs in pharmacokinetics and toxicokinetics. Drug Inf. J. 29:1995;997-1019.
17. Sheiner L.B., Beal S.L. Evaluation of methods for estimating pharmacokinetic parameters III, Monoexponential model. routine clinical pharmacokinetic data J. Pharmacokin. Biopharm. 11:1983;303-319.
18. Statistical Sciences, 1993. S-PLUS Guide to Statistical and Mathematical Analysis, Version 3.2, Seattle, StatSci, a division of MathSoft, Inc.
19. Wang J., Endreny L. A computationally efficient approach for the design of population pharmacokinetic studies. J. Pharmacokin. Biopharm. 20:1992;279-294.
20. White L.V. An extension of the general equivalence theorem to nonlinear models. Biometrika. 60:1973;345-348.